# Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

> **NCT00412789** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 15 (actual)

## Conditions studied

- Tumors

## Interventions

- **DRUG:** Patupilone

## Key facts

- **NCT ID:** NCT00412789
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-01
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2010-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412789, "Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00412789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*